Molecular Imaging-Guided Theranostics and Personalized Medicine

Hong Zhang 1 and Mei Tian 2 and Enzhong Li 3 and Yasuhisa Fujibayashi 4 and Lie-Hang Shen 5 and David J. Yang 2 1, Department of Nuclear Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Zhejiang, Hangzhou 310009, China 2, Department of Experimental Diagnostic Imaging, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevrd, P.O. Box 59 Houston, TX 77030, USA 3, Department of Health Sciences, National Natural Science Foundation of China, Beijing, China 4, National Institute of Radiological Sciences, Chiba, Japan 5, Isotope Application Division, Institute of Nuclear Energy Research, 1000, Wenhua Road, Jiaan Village, Taoyuan County, Longtan Township 32546, Taiwan Received 20 May 2012; Accepted 20 May 2012 This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Molecular imaging modalities include positron emission tomography (PET), single photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), computed tomography (CT), ultrasound (US), and optical (Raman, quantum dots, bioluminescence).